research News

PITTSBURGH, PA – Common neuropsychiatric symptoms that doctors see in Alzheimer’s disease patients originate from brain inflammation rather than amyloid and tau proteins, report University of Pittsburgh School of Medicine researchers today in. The finding strengthens mounting evidence for the role of neuroinflammation in Alzheimer’s progression and suggests new pathways...
Sharjah, United Arab Emirates – Anti-N-methyl-d-aspartate (Anti-NMDA) receptor encephalitis is an acute autoimmune disorder that develops both neurological symptoms and psychiatric symptoms, including hallucination, cognitive disturbance, epilepsy, movement disorder and impaired consciousness. This disease may be misdiagnosed at the early stage as a psychosis disease because of primary psychiatric symptoms....
Amsterdam, The Netherlands – There are several risk factors for the development of Alzheimer’s disease and vascular dementia. Based on an increasing number of studies linking these risk factors with Vitamin D deficiency, an article in the current issue of the Journal of Alzheimer’s Disease (May 2009) by William B....
The Food and Drug Administration (FDA) has updated the fact sheet for the Janssen COVID-19 vaccine to include information related to the potential increased risk of developing Guillain-Barré syndrome. Guillain-Barré syndrome is a rare neurological disorder in which the body’s immune system damages nerve cells causing muscle weakness and sometimes...